Medical Treatment of the Ductus Arteriosus
- 1 February 1977
- journal article
- research article
- Published by Taylor & Francis in Hospital Practice
- Vol. 12 (2) , 57-65
- https://doi.org/10.1080/21548331.1977.11707078
Abstract
Prostaglandin administered by aortic infusion prevents ductus closure when this is desirable—as in term infants with pulmonary atresia or critical pulmonic stenosis—raising arterial oxygen tension to levels compatible with life. On the other hand, in prematures with persistent patency of the ductus, administering indomethacin inhibits prostaglandin synthesis, inducing closure, and can obviate surgery.Keywords
This publication has 9 references indexed in Scilit:
- Closure of the Ductus Arteriosus in Premature Infants by Inhibition of Prostaglandin SynthesisNew England Journal of Medicine, 1976
- Pharmacologic Closure of Patent Ductus Arteriosus in the Premature InfantNew England Journal of Medicine, 1976
- Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero.Circulation Research, 1976
- E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.Circulation, 1976
- Formalin Infiltration of the Ductus ArteriosusNew England Journal of Medicine, 1975
- Lamb ductus arteriosus: Effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2Prostaglandins, 1975
- Studies on closure of the ductus arteriosus. XI. Ductal closure by a prostaglandin synthetase inhibitorProstaglandins, 1974
- The effects of prostaglandins, prostaglandin inhibitors, and oxygen on the closure of the ductus arteriosus, pulmonary arteries and umbilical vessels in vitroProstaglandins, 1974
- The Response of the Ductus Arteriosus to ProstaglandinsCanadian Journal of Physiology and Pharmacology, 1973